Wall Street Experts
ver. ZuMIgo(08/25)
Edwards Lifesciences Corporation
Rachunek Zysków i Strat
Przychody TTM (mln): 5 873
EBIT TTM (mln): 1 553
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
Rok finansowy |
1999 |
2000 |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
905 |
804 |
692 |
704 |
860 |
932 |
998 |
1,037 |
1,091 |
1,238 |
1,321 |
1,447 |
1,679 |
1,900 |
2,046 |
2,323 |
2,494 |
2,964 |
3,435 |
3,723 |
4,348 |
4,386 |
5,232 |
5,382 |
6,005 |
5,440 |
Przychód Δ r/r |
0.0% |
-11.2% |
-13.9% |
1.7% |
22.2% |
8.3% |
7.1% |
3.9% |
5.2% |
13.4% |
6.8% |
9.5% |
16.0% |
13.2% |
7.7% |
13.6% |
7.4% |
18.8% |
15.9% |
8.4% |
16.8% |
0.9% |
19.3% |
2.9% |
11.6% |
-9.4% |
Marża brutto |
48.5% |
47.4% |
53.2% |
57.5% |
58.2% |
60.3% |
62.5% |
64.0% |
65.3% |
66.1% |
69.8% |
71.8% |
70.8% |
74.0% |
74.5% |
73.1% |
75.2% |
73.1% |
74.5% |
74.8% |
74.4% |
75.4% |
76.1% |
79.9% |
77.0% |
79.5% |
EBIT (mln) |
117 |
95 |
24 |
52 |
138 |
154 |
176 |
173 |
173 |
198 |
238 |
284 |
300 |
408 |
454 |
483 |
643 |
784 |
1,023 |
748 |
1,147 |
1,628 |
1,348 |
1,748 |
1,534 |
1,379 |
EBIT Δ r/r |
0.0% |
-18.8% |
-74.7% |
117.1% |
165.6% |
11.6% |
13.7% |
-1.4% |
-0.3% |
14.9% |
20.0% |
19.5% |
5.6% |
36.1% |
11.3% |
6.2% |
33.2% |
22.0% |
30.5% |
-26.8% |
53.3% |
42.0% |
-17.2% |
29.7% |
-12.3% |
-10.1% |
EBIT (%) |
12.9% |
11.8% |
3.5% |
7.4% |
16.1% |
16.6% |
17.6% |
16.7% |
15.8% |
16.0% |
18.0% |
19.6% |
17.9% |
21.5% |
22.2% |
20.8% |
25.8% |
26.4% |
29.8% |
20.1% |
26.4% |
37.1% |
25.8% |
32.5% |
25.5% |
25.3% |
Koszty finansowe (mln) |
0 |
0 |
23 |
12 |
13 |
14 |
10 |
10 |
9 |
7 |
1 |
2 |
3 |
4 |
5 |
11 |
9 |
8 |
3 |
-2 |
21 |
16 |
18 |
19 |
18 |
20 |
EBITDA (mln) |
197 |
489 |
158 |
137 |
216 |
320 |
281 |
228 |
249 |
174 |
238 |
299 |
317 |
424 |
387 |
-177 |
650 |
885 |
999 |
1,390 |
1,331 |
1,736 |
1,483 |
1,830 |
1,945 |
1,723 |
EBITDA(%) |
21.8% |
60.8% |
22.8% |
19.4% |
25.1% |
34.4% |
28.2% |
22.0% |
22.8% |
14.1% |
18.0% |
20.7% |
18.9% |
22.3% |
18.9% |
-7.6% |
26.1% |
29.9% |
29.1% |
37.3% |
30.6% |
39.6% |
28.3% |
34.0% |
32.4% |
31.7% |
Podatek (mln) |
31 |
13 |
1 |
0 |
14 |
28 |
37 |
42 |
37 |
36 |
75 |
50 |
47 |
98 |
124 |
333 |
128 |
168 |
413 |
39 |
120 |
93 |
199 |
246 |
199 |
152 |
Zysk Netto (mln) |
82 |
-272 |
-12 |
56 |
79 |
2 |
79 |
130 |
113 |
129 |
229 |
218 |
237 |
293 |
392 |
811 |
495 |
570 |
622 |
722 |
1,047 |
823 |
1,503 |
1,522 |
1,402 |
4,175 |
Zysk netto Δ r/r |
0.0% |
-431.7% |
-95.6% |
-564.2% |
41.8% |
-97.8% |
4564.7% |
64.6% |
-13.4% |
14.1% |
77.7% |
-4.8% |
8.6% |
23.9% |
33.6% |
107.1% |
-39.0% |
15.1% |
9.2% |
16.1% |
45.0% |
-21.3% |
82.5% |
1.3% |
-7.9% |
197.7% |
Zysk netto (%) |
9.1% |
-33.8% |
-1.7% |
7.9% |
9.2% |
0.2% |
7.9% |
12.6% |
10.4% |
10.4% |
17.3% |
15.1% |
14.1% |
15.4% |
19.1% |
34.9% |
19.8% |
19.2% |
18.1% |
19.4% |
24.1% |
18.8% |
28.7% |
28.3% |
23.4% |
76.7% |
EPS |
0.12 |
-0.39 |
-0.017 |
0.0783 |
0.11 |
0.0025 |
0.11 |
0.19 |
0.16 |
0.19 |
0.34 |
0.32 |
0.35 |
0.43 |
0.59 |
1.27 |
0.77 |
0.89 |
0.98 |
1.15 |
1.68 |
1.32 |
2.41 |
2.46 |
2.31 |
6.98 |
EPS (rozwodnione) |
0.12 |
-0.39 |
-0.017 |
0.0758 |
0.11 |
0.0025 |
0.11 |
0.18 |
0.16 |
0.18 |
0.33 |
0.31 |
0.33 |
0.41 |
0.57 |
1.25 |
0.75 |
0.87 |
0.96 |
1.13 |
1.64 |
1.3 |
2.38 |
2.44 |
2.3 |
6.97 |
Ilośc akcji (mln) |
697 |
697 |
707 |
708 |
709 |
715 |
715 |
702 |
688 |
670 |
676 |
682 |
688 |
689 |
670 |
639 |
646 |
639 |
633 |
628 |
625 |
623 |
623 |
619 |
607 |
598 |
Ważona ilośc akcji (mln) |
697 |
697 |
707 |
736 |
733 |
744 |
748 |
767 |
752 |
715 |
704 |
715 |
716 |
710 |
683 |
651 |
661 |
653 |
648 |
641 |
637 |
632 |
631 |
624 |
609 |
599 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |